• 1
    Batty DG, Shipley M, Gunnell D, et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol. 2009;7:137152.
  • 2
    Ying LC, Barzi F, Woodward M, et al. Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21 000 deaths in 510 000 men and women. Int J Epidemiol. 2009;38:10601071.
  • 3
    Gertler MM, Gran SN, White PD. Young candidates for coronary heart disease. JAMA. 1951;147:621625.
  • 4
    Yarnell JW, Limb ES, Layzell JM, Baker IA. Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies. Eur Heart J. 1992;13:16021605.
  • 5
    Cook NR, Herbert PR, Satterfield S, et al. Height, lung function, and mortality from cardiovascular disease among the elderly. Am J Epidemiol. 1994;139:10661076.
  • 6
    Rich-Edwards JW, Manson JE, Stampfer MJ, et al. Height and the risk of cardiovascular disease in women. Am J Epidemiol. 1995;142:909917.
  • 7
    Wannamethee SG, Shaper AG, Whincup PH, Walker M. Adult height, stroke, and coronary heart disease. Am J Epidemiol. 1998;148:10691076.
  • 8
    Jousilahti P, Tuomilehto J, Vartiainen E, et al. Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31.199 middle-aged men and women in Finland. Am J Epidemiol. 2000;151:11121120.
  • 9
    Forsén T, Eriksson J, Qiao Q, et al. Short stature and coronary heart disease: a 35-year follow-up of the Finnish cohorts of the Seven Countries Study. J Intern Med. 2000;248:326332.
  • 10
    Kannam JP, Levy D, Larson M, Wilson PW. Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study. Circulation. 1994;90:22412247.
  • 11
    Goldbourt U, Tanne D. Body height is associated with decreased long-term stroke but not coronary heart disease mortality? Stroke. 2002;33:743748.
  • 12
    Paajanen TA, Oksala NKJ, Kuukasjärvi P, Karhunen PJ. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J. 2010;31:18021809.
  • 13
    Herbert PR, Rich-Edwards JW, Manson JE, et al. Height and incidence of cardiovascular disease in male physicians. Circulation. 1993;88:14371443.
  • 14
    Liao Y, McGee DL, Cao G, Cooper RS. Short stature and risk of mortality and cardiovascular disease: negative findings from the NHANES I epidemiologic follow-up study [Internet]. J Am Coll Cardiol. 1996;27:678682.
  • 15
    Song YM, Smith GD, Sung J. Adult height and cause-specific mortality: a large prospective study of South Korean men. Am J Epidemiol. 2003;158:479485.
  • 16
    Langenberg C, Hardy R, Breeze E, et al. Influence of short stature on the change in pulse pressure, systolic and diastolic blood pressure from age 36 to 53 years: an analysis using multilevel models. Int J Epidemiol. 2005;34:905913.
  • 17
    Langenberg C, Shipley MJ, Batty GD, Marmot MG. Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health. 2005;95:628632.
  • 18
    Voors AW, Harsha DW, Webber LS, Berenson GS. Relation of blood pressure to stature in healthy young adults. Am J Epidemiol. 1982;115:833840.
  • 19
    Coll de Tuero G, Foguet Q, Rodriguez A, et al. Assessment of self-monitoring blood pressure in the diagnosis of isolated clinic hypertension. Blood Press. 2006;15:227236.
  • 20
    Mancia G, de Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:11051187.
  • 21
    Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461470.
  • 22
    Dalfo A, Lopez-Contreras J, Gil M. Electrocardiographic diagnosis of left ventricular hypertrophy (LVH). Proposal of modification of Cornell criteria. Am J Hypertens. 1997;10:206A.
  • 23
    Saez M, González-Vázquez S, González-Penedo M, et al. Development of an automated system to classify retinal vessels into arteries and veins. Comput Methods Programs Biomed. 2012;108:367376.
  • 24
    Vázquez SG, Barreira N, Penedo MG, Rodriguez-Blanco M. The significance of the vessel registration for a reliable computation of arteriovenous ratio. ICIAR. 2012;2:347354.
  • 25
    Lauer MS, Anderson KM, Levy D. Influences of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry. The Framingham Heart Study. J Am Coll Cardiol. 1991;18:12871294.
  • 26
    Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997;95:14641470.
  • 27
    van Empel VP, De Windt LJ. Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc Res. 2004;63:487499.
  • 28
    Lauer MS, Larson MG, Levy D. Sex-specific reference M-mode values in adults: population-derived values with consideration of the impact of height. J Am Coll Cardiol. 1995;26:10391046.
  • 29
    Vasan RS, Larson MG, Levy D, et al. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framnigham Heart Study. Formulation of a height- and gender-specific classification and it prospective validation. Circulation. 1997;96:18631873.
  • 30
    de Simone G, Kizer JR, Chinali M, et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy the Strong Heart Study. Am J Hypertens. 2005;18:191196.
  • 31
    Norman JE, Levy D. Adjustement of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity. J Electrocardiol. 1996;29(Suppl):241247.
  • 32
    de Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension. 2001;38:1318.
  • 33
    Okin PM, Jern S, Devereux RB, et al. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension. 2000;1:1318.
  • 34
    Coll deTuero G, Mata Cases M, Rodriguez Poncelas A, et al. Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. BMC Nephrol. 2012;13:87.
  • 35
    Cheung CY, Ikram MK, Sabanayagam CH, Wong TY. Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension. 2012;60:10941103.
  • 36
    Barker DJP. The fetal and infant origins of disease. Eur J Clin Invest. 1995;25:457463.